{"database": "openregs", "table": "documents", "rows": [["FDA-1999-D-0010-0001", "FDA", "FDA-1999-D-0010", "Draft Guidance for Industry on in Vivo Pharmacokinetics and Bioavailability Studies and in Vitro Dissolution Testing for Levothyroxine Sodium Tablets; Availability", "Notice", "Notice of Data Availability", "1999-06-15T00:00:00Z", 1999, 6, "1999-06-15T00:00:00Z", "1999-08-10T03:59:59Z", "2025-05-28T09:01:12Z", "99-14751", 0, 0, "09000064804a59e3"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-1999-D-0010-0001"], "units": {}, "query_ms": 25.506086880341172, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}